189 related articles for article (PubMed ID: 9593135)
1. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.
Louie A; Drusano GL; Banerjee P; Liu QF; Liu W; Kaw P; Shayegani M; Taber H; Miller MH
Antimicrob Agents Chemother; 1998 May; 42(5):1105-9. PubMed ID: 9593135
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.
Louie A; Deziel M; Liu W; Drusano MF; Gumbo T; Drusano GL
Antimicrob Agents Chemother; 2005 Dec; 49(12):5058-68. PubMed ID: 16304173
[TBL] [Abstract][Full Text] [Related]
3. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.
Andes D; van Ogtrop M
Antimicrob Agents Chemother; 1999 Sep; 43(9):2116-20. PubMed ID: 10471550
[TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Andes D; Marchillo K; Stamstad T; Conklin R
Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.
Aviles P; Falcoz C; San Roman R; Gargallo-Viola D
Antimicrob Agents Chemother; 2000 Sep; 44(9):2333-40. PubMed ID: 10952576
[TBL] [Abstract][Full Text] [Related]
6. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis.
Andes D; Marchillo K; Conklin R; Krishna G; Ezzet F; Cacciapuoti A; Loebenberg D
Antimicrob Agents Chemother; 2004 Jan; 48(1):137-42. PubMed ID: 14693531
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
Andes D; Stamsted T; Conklin R
Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model.
Andes D; van Ogtrop M
Antimicrob Agents Chemother; 2000 Apr; 44(4):938-42. PubMed ID: 10722494
[TBL] [Abstract][Full Text] [Related]
10.
Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
Debruyne D
Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
[No Abstract] [Full Text] [Related]
13. Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
Gonzalez JM; Rodriguez CA; Zuluaga AF; Agudelo M; Vesga O
PLoS One; 2015; 10(11):e0141872. PubMed ID: 26536105
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
Cojutti PG; Lugano M; Righi E; Della Rocca G; Bassetti M; Hope W; Pea F
Eur J Clin Pharmacol; 2018 Nov; 74(11):1449-1459. PubMed ID: 30032414
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.
Andes D; Marchillo K; Stamstad T; Conklin R
Antimicrob Agents Chemother; 2003 Apr; 47(4):1193-9. PubMed ID: 12654646
[TBL] [Abstract][Full Text] [Related]
16. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
[TBL] [Abstract][Full Text] [Related]
17. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
18. Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose.
Eschenauer GA; Carver PL; Patel TS; Lin SW; Klinker KP; Pai MP; Lam SW
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581112
[TBL] [Abstract][Full Text] [Related]
19. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).
Ratzlaff K; Papich MG; Flammer K
J Avian Med Surg; 2011 Mar; 25(1):23-31. PubMed ID: 21657184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
